Selective Autophagy in Hyperglycemia-Induced Microvascular and Macrovascular Diseases
- PMID: 34440882
- PMCID: PMC8392047
- DOI: 10.3390/cells10082114
Selective Autophagy in Hyperglycemia-Induced Microvascular and Macrovascular Diseases
Abstract
Dysregulation of autophagy is an important underlying cause in the onset and progression of many metabolic diseases, including diabetes. Studies in animal models and humans show that impairment in the removal and the recycling of organelles, in particular, contributes to cellular damage, functional failure, and the onset of metabolic diseases. Interestingly, in certain contexts, inhibition of autophagy can be protective. While the inability to upregulate autophagy can play a critical role in the development of diseases, excessive autophagy can also be detrimental, making autophagy an intricately regulated process, the altering of which can adversely affect organismal health. Autophagy is indispensable for maintaining normal cardiac and vascular structure and function. Patients with diabetes are at a higher risk of developing and dying from vascular complications. Autophagy dysregulation is associated with the development of heart failure, many forms of cardiomyopathy, atherosclerosis, myocardial infarction, and microvascular complications in diabetic patients. Here, we review the recent findings on selective autophagy in hyperglycemia and diabetes-associated microvascular and macrovascular complications.
Keywords: ER-phagy; autophagy; cardiovascular; diabetes; endoplasmic reticulum; lysosome; mitochondria; mitophagy; pexophagy; pexoxisome; reactive oxygen species (ROS).
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Selective autophagy of intracellular organelles: recent research advances.Theranostics. 2021 Jan 1;11(1):222-256. doi: 10.7150/thno.49860. eCollection 2021. Theranostics. 2021. PMID: 33391472 Free PMC article.
-
Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles.Autophagy. 2021 Feb;17(2):385-401. doi: 10.1080/15548627.2020.1725377. Epub 2020 Feb 12. Autophagy. 2021. PMID: 32048886 Free PMC article. Review.
-
Autophagy-nutrient sensing pathways in diabetic complications.Pharmacol Res. 2022 Oct;184:106408. doi: 10.1016/j.phrs.2022.106408. Epub 2022 Aug 18. Pharmacol Res. 2022. PMID: 35988870 Review.
-
Autophagy and mitophagy in diabetic cardiomyopathy.Biochim Biophys Acta. 2015 Feb;1852(2):252-61. doi: 10.1016/j.bbadis.2014.05.020. Epub 2014 May 29. Biochim Biophys Acta. 2015. PMID: 24882754 Review.
-
Calpain Inhibition Restores Autophagy and Prevents Mitochondrial Fragmentation in a Human iPSC Model of Diabetic Endotheliopathy.Stem Cell Reports. 2019 Mar 5;12(3):597-610. doi: 10.1016/j.stemcr.2019.01.017. Epub 2019 Feb 21. Stem Cell Reports. 2019. PMID: 30799273 Free PMC article.
Cited by
-
Acute Hyperglycemia-Induced Injury in Myocardial Infarction.Int J Mol Sci. 2024 Aug 4;25(15):8504. doi: 10.3390/ijms25158504. Int J Mol Sci. 2024. PMID: 39126075 Free PMC article. Review.
-
Targeting autophagy with natural products as a potential therapeutic approach for diabetic microangiopathy.Front Pharmacol. 2024 Apr 10;15:1364616. doi: 10.3389/fphar.2024.1364616. eCollection 2024. Front Pharmacol. 2024. PMID: 38659578 Free PMC article. Review.
-
Glp-1 Mimetics and Autophagy in Diabetic Milieu: State-of-the-Art.Curr Diabetes Rev. 2024;20(10):e250124226181. doi: 10.2174/0115733998276570231222105959. Curr Diabetes Rev. 2024. PMID: 38299271 Review.
-
Restoring glucose balance: Conditional HMGB1 knockdown mitigates hyperglycemia in a Streptozotocin induced mouse model.Heliyon. 2023 Dec 12;10(1):e23561. doi: 10.1016/j.heliyon.2023.e23561. eCollection 2024 Jan 15. Heliyon. 2023. PMID: 38187339 Free PMC article.
-
Effect of exercise on improving myocardial mitochondrial function in decreasing diabetic cardiomyopathy.Exp Physiol. 2024 Feb;109(2):190-201. doi: 10.1113/EP091309. Epub 2023 Oct 16. Exp Physiol. 2024. PMID: 37845840 Free PMC article. Review.
References
-
- Mohammedi K., Woodward M., Hirakawa Y., Zoungas S., Williams B., Lisheng L., Rodgers A., Mancia G., Neal B., Harrap S., et al. Microvascular and macrovascular disease and risk for major peripheral arterial disease in patients with type 2 diabetes. Diabetes Care. 2016;39:1796–1803. doi: 10.2337/dc16-0588. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical